Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free PTPI Stock Alerts $0.61 +0.03 (+5.14%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Petros Pharmaceuticals Stock Price Performance5 Day Performance+0.11%1 Month Performance-9.28%3 Month Performance-63.22%6 Month Performance-58.22%Year-To-Date Performance-56.44%1 Year Performance-74.93% Receive PTPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. PTPI Stock Chart for Sunday, June, 2, 2024 PTPI Chart by TradingView Petros Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.59$0.61+4.92%$0.64$0.5955,644 shs$4.30 million05/30/2024$0.62$0.59-4.98%$0.64$0.56141,695 shs$4.10 million05/29/2024$0.61$0.62+0.42%$0.68$0.62251,749 shs$4.31 million05/28/2024$0.61$0.61+0.57%$0.65$0.6033,588 shs$4.29 million05/27/2024$0.61$0.61$0.66$0.6059,600 shs$4.27 million05/24/2024$0.61$0.61-0.47%$0.66$0.6056,179 shs$4.27 million Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.65$0.61-5.75%$0.67$0.6177,249 shs$4.29 million05/22/2024$0.65$0.65+0.09%$0.68$0.6563,485 shs$4.55 million05/21/2024$0.62$0.65+3.97%$0.72$0.64311,382 shs$4.55 million05/20/2024$0.59$0.62+6.64%$0.63$0.59133,426 shs$4.37 million05/17/2024$0.55$0.59+6.91%$0.59$0.55114,486 shs$4.03 million05/16/2024$0.52$0.55+6.30%$0.57$0.53168,952 shs$3.77 million05/15/2024$0.60$0.52-13.92%$0.62$0.50298,734 shs$3.55 million05/14/2024$0.61$0.60-2.28%$0.65$0.58301,067 shs$4.12 million05/13/2024$0.64$0.61-3.97%$0.64$0.61156,148 shs$4.22 million05/10/2024$0.64$0.64-0.41%$0.68$0.6366,339 shs$4.39 million05/09/2024$0.65$0.64-0.62%$0.67$0.6378,545 shs$4.41 million05/08/2024$0.69$0.65-5.84%$0.69$0.63102,466 shs$4.44 million05/07/2024$0.69$0.69-1.01%$0.70$0.6880,576 shs$4.71 million05/06/2024$0.71$0.69-2.99%$0.72$0.68140,135 shs$4.76 million05/03/2024$0.68$0.71+5.36%$0.77$0.69373,689 shs$4.91 million05/02/2024$0.66$0.68+3.04%$0.71$0.67117,556 shs$4.66 million05/01/2024$0.66$0.66+0.08%$0.68$0.64142,751 shs$4.52 million04/30/2024$0.70$0.66-6.76%$0.70$0.64120,693 shs$4.52 million04/29/2024$0.64$0.70+10.03%$0.71$0.65155,404 shs$4.84 million04/26/2024$0.64$0.64$0.66$0.6377,209 shs$4.40 million04/25/2024$0.63$0.64+0.87%$0.65$0.60217,698 shs$4.40 million04/24/2024$0.68$0.63-6.72%$0.69$0.62184,764 shs$4.37 million04/23/2024$0.65$0.68+4.60%$0.71$0.64613,565 shs$4.68 million04/22/2024$0.67$0.65-2.97%$0.69$0.63201,094 shs$4.47 million04/19/2024$0.70$0.68-2.91%$0.70$0.67161,629 shs$4.66 million04/18/2024$0.69$0.70+1.14%$0.73$0.65230,520 shs$4.80 million04/17/2024$0.71$0.69-2.13%$0.73$0.64457,077 shs$4.74 million04/16/2024$0.78$0.71-9.97%$0.90$0.661.94 million shs$4.85 million04/15/2024$0.83$0.78-6.09%$0.82$0.74542,781 shs$5.39 million04/12/2024$0.91$0.83-8.36%$0.91$0.83346,125 shs$1.84 million04/11/2024$0.89$0.91+2.76%$0.94$0.84348,695 shs$2.00 million04/10/2024$0.91$0.89-2.79%$0.91$0.81375,946 shs$1.95 million04/09/2024$0.93$0.91-2.18%$0.94$0.89199,052 shs$2.00 million04/08/2024$0.93$0.93+0.67%$0.95$0.88388,043 shs$2.05 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$0.95$0.93-2.62%$0.95$0.92239,389 shs$2.04 million04/04/2024$0.93$0.95+2.15%$1.00$0.91421,152 shs$2.09 million04/03/2024$1.07$0.93-13.08%$1.03$0.901.31 million shs$2.05 million04/02/2024$1.40$1.07-23.57%$1.22$1.012.00 million shs$2.35 million04/01/2024$1.48$1.40-5.41%$1.48$1.39314,589 shs$3.08 million03/29/2024$1.48$1.48$1.52$1.42378,806 shs$3.26 million03/28/2024$1.45$1.48+2.07%$1.52$1.42367,507 shs$3.26 million03/27/2024$1.55$1.45-6.45%$1.52$1.39754,292 shs$3.19 million03/26/2024$1.57$1.55-1.27%$1.58$1.48729,235 shs$3.41 million03/25/2024$1.50$1.57+4.67%$1.59$1.46557,993 shs$3.45 million03/22/2024$1.50$1.50$1.55$1.44633,185 shs$3.30 million03/21/2024$1.41$1.50+6.38%$1.54$1.36762,038 shs$3.30 million03/20/2024$1.45$1.41-2.76%$1.43$1.34938,675 shs$3.10 million03/19/2024$1.47$1.45-1.36%$1.67$1.415.10 million shs$3.19 million03/18/2024$1.52$1.47-3.29%$1.60$1.45321,533 shs$3.23 million03/15/2024$1.38$1.52+10.14%$1.58$1.40814,211 shs$3.34 million03/14/2024$1.44$1.38-3.83%$1.41$1.30537,491 shs$3.04 million03/13/2024$1.49$1.44-3.69%$1.50$1.42442,466 shs$3.16 million03/12/2024$1.56$1.49-4.49%$1.56$1.47769,256 shs$3.28 million03/11/2024$1.63$1.56-4.29%$1.65$1.56499,647 shs$3.43 million03/08/2024$1.50$1.63+8.67%$1.65$1.52762,912 shs$3.59 million03/07/2024$1.60$1.50-6.25%$1.60$1.50353,188 shs$3.30 million03/06/2024$1.51$1.60+5.96%$1.63$1.47784,914 shs$3.52 million03/05/2024$1.63$1.51-7.36%$1.61$1.46965,625 shs$3.32 million03/04/2024$1.67$1.63-2.40%$1.66$1.56547,851 shs$3.59 million03/01/2024$1.72$1.67-2.91%$1.75$1.62653,623 shs$3.67 million Related Companies: Galecto Stock Chart Minerva Neurosciences Stock Chart Tonix Pharmaceuticals Stock Chart Orgenesis Stock Chart Traws Pharma Stock Chart NeuroSense Therapeutics Stock Chart Akari Therapeutics Stock Chart Kiora Pharmaceuticals Stock Chart Edesa Biotech Stock Chart FSD Pharma Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.